Pricing and reimbursement of drugs in Sweden

European Journal of Health Economics

Volumn 3, Issue 1, 2002, Pages 66-67

  Lundkvist, Jonas ^a  

^a STOCKHOLM HEALTH ECONOMICS   (Sweden)

Author keywords

Drug cost; Health care systems; Pricing; Reimbursement

Indexed keywords

DRUG COST; ECONOMIC EVALUATION; IMPOTENCE; OBESITY; PRIORITY JOURNAL; PROSPECTIVE PRICING; PUBLIC HEALTH SERVICE; REIMBURSEMENT; REVIEW; SOCIAL INSURANCE; SWEDEN;

EID: 0010279283     PISSN: 16187598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10198-001-0094-1     Document Type: Review

References (17)

1. National Board of Health and Welfare (2001) Yearbook of health and medical care 2000. National Board of Health and Welfare: Stockholm (in Swedish)
2. Axelsson R (1998) Hälso-och sjukvårds-administration i organisationsteoretisk belysning. Studentlitteratur: Lund (in Swedish)
3. World Health Organization (1996) Health care systems in transition Sweden. World Health Organization Regional Office for Europe, Department of Health Policy and Services: Copenhagen
4. Swedish Federation of County Councils (2001) Information about the County Councils. Swedish Federation of County Councils (in Swedish)
5. Burman K (2001) Swedish drug statistics 2000. Apoteket AB: Stockholm (in Swedish)
6. Anell A, Jönsson B, Persson U (1998) Läkemedelskostnaderna. IHE and Stockholm School of Economics: Lund (in Swedish)
7. National Social Insurance Board (1999) Prissättning av läkemedel - svenska läkemedelspriser i ett internationellt perspektiv. NSIB report 1999: 10. Riksförsäkringsverket, Division of Drug Affairs: Stockholm (in Swedish)
8. Ministry of Health and Social Affairs (2001) Lag om högkostnadsskydd vid köp av läkemedel m.m (The cost limitation of purchase of medicinal products). Pub. L no. SFS1996:1150. Ministry of Health and Social Affairs (in Swedish)
9. Ministry of Health and Social Affairs (1997) Förordning om högkostnadsskydd vid köp av läkemedel m.m (The cost limitation of purchase of medicinal products etc.). Pub. L. no. SFS 1996:1294. Ministry of Health and Social Affairs (in Swedish)
10. National Social Insurance Board (2001) Pricing and reimbursement of pharmaceuticals in Sweden. Riksförsäkringsverket: Stockholm (in Swedish)
11. National Social Insurance Board (2001) Riksförsäkringsverkets föreskrifter om fastställande av pris på läkemedel m.m (Ordinance of the NSIB on the pricing of medical products). Pub.L.no.RFFS 1996:31. Riksförsäkringsverket: Stockholm (in Swedish)
12. National Social Insurance Board (2001) Nya läkemedel prissatta 1998 och 1999 - hälsoekonomiska underlag och internationella priser. NSIB report 2001:5. Riksförsäkringsverket, Division of Drug Affairs: Stockholm (in Swedish)
13. Burman K (2000) Swedish drug statistics 1999. Apoteket AB: Stockholm (in Swedish)
14. Gerdtham U (2001) Läkemedelsprisindex och kostnadsutveckling. In: Jönsson B (ed) Läkemedel: Kostnad eller resurs for sjukvården. Stockholm School of Economics: Stockholm
15. National Social Insurance Board (2000) Parallellimporterade läkemedel - inte till vilket pris som helst. NSIB report 2000:6. Riksförsäkringsverket, Division of Drug Affairs: Stockholm (in Swedish)
16. Ekelund M (2000) Competition and innovation in the Swedish pharmaceutical market. Stockholm School of Economics, thesis
17. Edhag O (2000) Den nya läkemedelsförmånen SOU (2000:86) Stockholm (in Swedish)